RDNT vs. FTRE, GH, VCYT, VRDN, FLGT, CSTL, CDNA, BDSX, BNR, and PSNL
Should you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fortrea (FTRE), Guardant Health (GH), Veracyte (VCYT), Viridian Therapeutics (VRDN), Fulgent Genetics (FLGT), Castle Biosciences (CSTL), CareDx (CDNA), Biodesix (BDSX), Burning Rock Biotech (BNR), and Personalis (PSNL). These companies are all part of the "medical laboratories" industry.
RadNet (NASDAQ:RDNT) and Fortrea (NASDAQ:FTRE) are both mid-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, media sentiment, earnings, risk, profitability, community ranking, dividends, valuation and analyst recommendations.
77.9% of RadNet shares are owned by institutional investors. 4.4% of RadNet shares are owned by company insiders. Comparatively, 0.1% of Fortrea shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
RadNet currently has a consensus price target of $53.67, indicating a potential upside of 4.33%. Fortrea has a consensus price target of $37.29, indicating a potential upside of 1.15%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Fortrea.
RadNet has a net margin of 0.19% compared to Fortrea's net margin of 0.00%. RadNet's return on equity of 4.72% beat Fortrea's return on equity.
In the previous week, Fortrea had 3 more articles in the media than RadNet. MarketBeat recorded 7 mentions for Fortrea and 4 mentions for RadNet. Fortrea's average media sentiment score of 0.98 beat RadNet's score of 0.64 indicating that Fortrea is being referred to more favorably in the news media.
RadNet has higher earnings, but lower revenue than Fortrea.
RadNet received 334 more outperform votes than Fortrea when rated by MarketBeat users. Likewise, 65.83% of users gave RadNet an outperform vote while only 38.46% of users gave Fortrea an outperform vote.
Summary
RadNet beats Fortrea on 11 of the 15 factors compared between the two stocks.
Get RadNet News Delivered to You Automatically
Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
